Back to Search
Start Over
Johnson & Johnson says Impella ECP met primary endpoint in high-risk PCI study
- Source :
- The Fly. October 28, 2024
- Publication Year :
- 2024
-
Abstract
- Results were presented at Transcatheter Cardiovascular Therapeutics, or TCT, 2024 conference from the first completed pivotal trial on patients supported with Impella ECP, a novel transvalvular axial flow pump with [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- The Fly
- Publication Type :
- Periodical
- Accession number :
- edsgcl.813879958